These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 188254)

  • 1. [Study of experimental chronic infection in mice caused by herpes simplex virus].
    Spynu KI; Vanag KA
    Vopr Virusol; 1976; (5):574-9. PubMed ID: 188254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cyclophosphane on the development of experimental chronic herpetic infection in animals].
    Spynu KI; Vanag KA; Barinskiĭ IF
    Vopr Virusol; 1977; (3):359-64. PubMed ID: 198970
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier.
    McKendall RR
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1965-72. PubMed ID: 6310036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of viremia in chronic human herpetic infection].
    Fomina AN; Shubladze AK; Davydova AA
    Vopr Virusol; 1977; (1):17-9. PubMed ID: 198957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent herpetic infections following experimental viraemia.
    Cook ML; Stevens JG
    J Gen Virol; 1976 Apr; 31(1):75-80. PubMed ID: 177731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tumours in mice chronically infected with herpes simplex virus.
    Barinsky IF; Spynu KI; Talalaeva AF; Vanag KA
    Acta Virol; 1979 Sep; 23(5):367-74. PubMed ID: 42295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 8. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
    Ennis FA
    J Infect Dis; 1973 Jun; 127(6):632-8. PubMed ID: 4350518
    [No Abstract]   [Full Text] [Related]  

  • 9. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
    Shimeld C; Hill TJ; Blyth WA; Easty DL
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice.
    Lopez C; Ryshke R; Bennett M
    Infect Immun; 1980 Jun; 28(3):1028-32. PubMed ID: 6249746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hamster model for herpes simplex virus infection of the central nervous system.
    van Ekdom LT; Herbrink P; Meddens MJ
    Infection; 1987; 15(2):125-7. PubMed ID: 3036713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
    Townsend JJ; Baringer JR
    Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection.
    Kino Y; Hayashi Y; Hayashida I; Mori R
    J Gen Virol; 1982 Dec; 63(2):475-9. PubMed ID: 6296289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.
    Zawatzky R; Hilfenhaus J; Marcucci F; Kirchner H
    J Gen Virol; 1981 Mar; 53(Pt 1):31-8. PubMed ID: 6168735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of a commercial vaccine, poludan and their combinations in an experimental herpes infection].
    Khaletskaia EV; Fadeeva LL; Selezneva AIu; Semenova TB
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Feb; (2):51-4. PubMed ID: 2437741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B; Allison AC
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of herpes simplex virus type-1 (Miyama +GC strain) to the central nervous system after intraperitoneal inoculation: the role of the myenteric plexus of the gut.
    Irie H; Harada Y; Yoshihashi H; Kimura T; Kojima M; Kataoka M; Saito M; Sugawara Y; Mori W
    Arch Virol; 1989; 105(3-4):247-57. PubMed ID: 2546519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
    Hill TJ; Field HJ; Blyth WA
    J Gen Virol; 1975 Sep; 28(3):341-53. PubMed ID: 170376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of the adrenal gland as a route to the central nervous system after viraemia with herpes simplex virus in the mouse.
    Hill TJ; Yirrell DL; Blyth WA
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():309-20. PubMed ID: 3003239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properties of herpes simplex virus strains isolated from patients with recurrent cutaneous herpes].
    Semenova TB; Posevaia TA; Vanag AI; Barinskiĭ IF
    Vopr Virusol; 1985; 30(1):93-6. PubMed ID: 2986361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.